Seok Soon Park Selected Research

pyrrolidine dithiocarbamic acid

1/2018

Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seok Soon Park Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 03/2012
9	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 08/2004
4	Lung Neoplasms (Lung Cancer) 09/2023 - 02/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2020
2	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Hypertrophic Cicatrix (Hypertrophic Scar) 12/2019
1	Fibrosis (Cirrhosis) 12/2019
1	Cicatrix (Scar) 12/2019
1	Cardiotoxicity 01/2018
1	Body Weight (Weight, Body) 03/2015
1	Adenocarcinoma of Lung 02/2015
1	Tauopathies 04/2011
1	Type 2 Diabetes Mellitus (MODY) 04/2011
1	Obesity 04/2011
1	Flushing 01/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 07/2005
4	LigandsIBA 01/2017 - 12/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 12/2008
2	Immunoconjugates (Immunoconjugate)IBA 08/2023 - 12/2021
2	Small Interfering RNA (siRNA)IBA 01/2023 - 03/2012
2	Trastuzumab (Herceptin)FDA Link 12/2021 - 01/2018
2	Peptides (Polypeptides)IBA 10/2020 - 02/2015
2	(5- (4- amino- 6- bromo- 5- carbamoyl- 1H- pyrrolo(2,3- d)pyrimidin- 1- yl)- 3,4- dihydroxytetrahydrofuran- 2- yl)methyl isobutyrateIBA 01/2017 - 08/2014
2	CaspasesIBA 11/2007 - 08/2004
1	Valosin Containing ProteinIBA 01/2024
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2024
1	phosphomevalonate kinaseIBA 09/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2023
1	Therapeutic UsesIBA 08/2023
1	Cytotoxins (Cytolysins)IBA 08/2023
1	AntibodiesIBA 08/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	human ERBB2 proteinIBA 12/2021
1	Human Serum Albumin FDA LinkGeneric 10/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2020
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 10/2020
1	SirtuinsIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	EnzymesIBA 12/2019
1	Type A Botulinum Toxins (Botox)FDA Link 12/2019
1	ImmunosorbentsIBA 12/2019
1	Sulfhydryl Compounds (Thiols)IBA 01/2019
1	gambogic acidIBA 01/2019
1	Cycloheximide (Cicloheximide)IBA 01/2019
1	pyrrolidine dithiocarbamic acidIBA 01/2018
1	prolinedithiocarbamate (PDTC)IBA 01/2018
1	NanocapsulesIBA 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	CalpainIBA 01/2017
1	GoldIBA 06/2015
1	CreatinineIBA 03/2015
1	Urea (Carbamide)FDA LinkGeneric 03/2015
1	ErbB Receptors (EGF Receptor)IBA 03/2015
1	NitrogenIBA 03/2015
1	ProdrugsIBA 08/2014
1	Caspase 3 (Caspase-3)IBA 03/2012
1	4- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazolineIBA 03/2012
1	SurvivinIBA 03/2012
1	Protein Isoforms (Isoforms)IBA 04/2011
1	QuercetinIBA 12/2008
1	FlavonoidsIBA 12/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2008
1	Cytochromes c (Cytochrome c)IBA 11/2007
1	RoscovitineIBA 09/2005
1	beta-Galactosidase (Lactaid)IBA 07/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2004
1	Chlorophyll AIBA 01/2003
1	MineralsIBA 01/2003

Therapy/Procedure

8	Therapeutics 01/2024 - 02/2015
7	Radiotherapy 09/2023 - 08/2014
1	Aftercare (After-Treatment) 11/2020
1	Precision Medicine 10/2020
1	Adjuvant Radiotherapy 10/2020
1	Neoadjuvant Therapy 10/2020
1	Drug Therapy (Chemotherapy) 01/2018
1	Chemoradiotherapy 08/2014